e-learning
resources
Stockholm 2007
Monday 17.09.2007
Diagnostic markers and therapy in hospital-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Ventilation-associated pneumonia: probability of occurence as a function of time
K. Romagnolo, A. Hirota, C. Tanaka, C. Fu (Sao Paulo, SP, Brazil)
Source:
Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Session:
Diagnostic markers and therapy in hospital-acquired pneumonia
Session type:
Thematic Poster Session
Number:
2410
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Romagnolo, A. Hirota, C. Tanaka, C. Fu (Sao Paulo, SP, Brazil). Ventilation-associated pneumonia: probability of occurence as a function of time. Eur Respir J 2007; 30: Suppl. 51, 2410
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Oxy-Met score: a new physiological index to predict mortality in community-acquired pneumonia
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
COPD: what is the frequency and impact of community-acquired pneumonia?
Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know?
Year: 2008
The main risk factors of the community-acquired pneumonia delayed course
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005
Management-based risk prediction in community-acquired pneumonia by scores and biomarkers
Source: Eur Respir J 2013; 41: 974-984
Year: 2013
Defining community-acquired pneumonia severity on presentation to hospital: a derivation study
Source: Eur Respir J 2004; 24: Suppl. 48, 186s
Year: 2004
3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors
Source: Eur Respir J 2016; 47:1572-1574
Year: 2016
The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course
Source: Eur Respir J 2006; 28: Suppl. 50, 351s
Year: 2006
Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Treatment failure of community-acquired pneumonia: risk factors and consequences
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007
Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia
Source: Annual Congress 2007 - Infections year in review
Year: 2007
Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2012; 39: 156-162
Year: 2012
Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2011; 39: 156-162
Year: 2012
Prevention is better than cure: time to change the focus of community-acquired pneumonia management
Source: Eur Respir J 2015; 45: 1524-1525
Year: 2015
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009
Lung vessel thrombosis like the reason of mortality at severe community-acquired pneumonia (CAP) of viral and bacterial etiology - autopsy data
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
Defining stability in pneumonia and the non-responding pneumonia
Source: Annual Congress 2005 - Outcome in severe pneumonia
Year: 2005
Initial risk class and length of hospital stay in community-acquired pneumonia
Source: Eur Respir J 2001; 18: 151-156
Year: 2001
Inflammatory responses predict long-term mortality risk in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 1439-1446
Year: 2011
Validation of a predictive rule for the management of community-acquired pneumonia
Source: Eur Respir J 2006; 27: 151-157
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept